Page 3 - Biocon Ltd News
Karnataka CM's remark on Covid vaccines 'factually incorrect': Biocon chief
Biocon founder Kiran Mazumdar-Shaw on Thursday opposed Karnataka Chief Minister Siddaramaiah's remarks linking covid-19 vaccines with a spate of heart attack deaths in the state's Hassan district, saying such claims are "'factually incorrect" and "misleading". Siddaramaiah has suggested that the recent heart attack deaths in Hassan district may be linked to the vaccination drive. He had also claimed the vaccines were 'hastily' approved. In a social media post, Shaw said "covid-19 vaccines developed in India were approved under the Emergency Use Authorisation framework, following rigorous protocols aligned with global standards for safety and efficacy. To suggest that these vaccines were 'hastily' approved is factually incorrect and contributes to public misinformation." "These vaccines have saved millions of lives and, like all vaccines, may cause side effects in a very small number of individuals. It is important to acknowledge the science and data-driven processes behind their ...
 "Karnataka CM's remark on Covid vaccines 'factually incorrect': Biocon chief")
Biocon climbs 3% on plans to file approvals for generic weight-loss drug
Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of Novo Nordisk A/S's Ozempic and Wegovy
 "Biocon climbs 3% on plans to file approvals for generic weight-loss drug")
Biocon Biologics to launch Eylea biosimilar Yesafili in Canada next month
Yesafili is the first Eylea biosimilar approved in Canada and Biocon Biologics' 10th commercialised biosimilar, with launch scheduled for July 4 across the country
 "Biocon Biologics to launch Eylea biosimilar Yesafili in Canada next month")
